BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 21525081)

  • 1. β-blockers for infantile hemangiomas: a single-institution experience.
    Blatt J; Morrell DS; Buck S; Zdanski C; Gold S; Stavas J; Powell C; Burkhart CN
    Clin Pediatr (Phila); 2011 Aug; 50(8):757-63. PubMed ID: 21525081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current concepts in the management of periocular infantile (capillary) hemangioma.
    Ni N; Guo S; Langer P
    Curr Opin Ophthalmol; 2011 Sep; 22(5):419-25. PubMed ID: 21730838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
    Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
    Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical timolol gel for infantile hemangiomas: a pilot study.
    Pope E; Chakkittakandiyil A
    Arch Dermatol; 2010 May; 146(5):564-5. PubMed ID: 20479314
    [No Abstract]   [Full Text] [Related]  

  • 5. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-four-hour hospitalization for patients initiating systemic propranolol therapy for infantile hemangiomas--is it indicated?
    Liu LS; Sokoloff D; Antaya RJ
    Pediatr Dermatol; 2013; 30(5):554-60. PubMed ID: 23829941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
    Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
    Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma.
    Denoyelle F; Leboulanger N; Enjolras O; Harris R; Roger G; Garabedian EN
    Int J Pediatr Otorhinolaryngol; 2009 Aug; 73(8):1168-72. PubMed ID: 19481268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical timolol for small hemangiomas of infancy.
    Moehrle M; Léauté-Labrèze C; Schmidt V; Röcken M; Poets CF; Goelz R
    Pediatr Dermatol; 2013; 30(2):245-9. PubMed ID: 22471694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
    Ge J; Zheng J; Zhang L; Yuan W; Zhao H
    Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.
    Holland KE; Frieden IJ; Frommelt PC; Mancini AJ; Wyatt D; Drolet BA
    Arch Dermatol; 2010 Jul; 146(7):775-8. PubMed ID: 20644039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm.
    Truong MT; Perkins JA; Messner AH; Chang KW
    Int J Pediatr Otorhinolaryngol; 2010 Sep; 74(9):1043-8. PubMed ID: 20674045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Timolol Maleate Treatment of Infantile Hemangiomas.
    Püttgen K; Lucky A; Adams D; Pope E; McCuaig C; Powell J; Feigenbaum D; Savva Y; Baselga E; Holland K; Drolet B; Siegel D; Morel KD; Garzon MC; Mathes E; Lauren C; Nopper A; Horii K; Newell B; Song W; Frieden I;
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27527799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas.
    Maturo S; Hartnick C
    Int J Pediatr Otorhinolaryngol; 2010 Mar; 74(3):323-5. PubMed ID: 20071038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
    Breur JM; de Graaf M; Breugem CC; Pasmans SG
    Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical timolol maleate for superficial infantile hemangiomas: an observational study.
    Xu DP; Cao RY; Tong S; Xue L; Sun NN; Wang XK
    J Oral Maxillofac Surg; 2015 Jun; 73(6):1089-94. PubMed ID: 25843815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.
    Celik A; Tiryaki S; Musayev A; Kismali E; Levent E; Ergun O
    J Drugs Dermatol; 2012 Jul; 11(7):808-11. PubMed ID: 22777220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol treatment for infantile hemangiomas.
    Buckmiller LM
    Curr Opin Otolaryngol Head Neck Surg; 2009 Dec; 17(6):458-9. PubMed ID: 19858718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical timolol for infantile hemangiomas: putting a note of caution in "cautiously optimistic".
    McMahon P; Oza V; Frieden IJ
    Pediatr Dermatol; 2012; 29(1):127-30. PubMed ID: 22256996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.